Mc Adam, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Mc Adam, LLC

$1.77 Billion
Q3 2024

A detailed history of Mc Adam, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Mc Adam, LLC holds 2,644 shares of REGN stock, worth $2.23 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,644

Previous 2,663 0.71%

Holding current value

$2.23 Million

Previous $2.8 Million 0.68%

% of portfolio

0.16%

Previous 0.17%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$1024.09 - $1201.76 $19,457 - $22,833	-19 Reduced 0.71%	2,644 $2.78 Million
Q2 2024 Jul 24, 2024	SELL	$883.2 - $1071.19 $22,963 - $27,850	-26 Reduced 0.97%	2,663 $2.8 Million
Q1 2024 Apr 23, 2024	BUY	$902.69 - $993.35 $3,610 - $3,973	4 Added 0.15%	2,689 $2.59 Million
Q4 2023 Feb 05, 2024	SELL	$775.18 - $881.7 $6,201 - $7,053	-8 Reduced 0.3%	2,685 $2.36 Million
Q3 2023 Oct 31, 2023	BUY	$692.45 - $844.37 $6,232 - $7,599	9 Added 0.34%	2,693 $2.22 Million
Q2 2023 Aug 02, 2023	BUY	$700.03 - $830.35 $11,900 - $14,115	17 Added 0.64%	2,684 $1.93 Million
Q1 2023 Apr 24, 2023	SELL	$680.49 - $826.97 $63,966 - $77,735	-94 Reduced 3.4%	2,667 $2.19 Million
Q4 2022 Jan 27, 2023	BUY	$705.89 - $766.39 $60,706 - $65,909	86 Added 3.21%	2,761 $1.74 Million
Q3 2022 Oct 24, 2022	BUY	$573.97 - $724.32 $573 - $724	1 Added 0.04%	2,675 $1.84 Million
Q2 2022 Jul 15, 2022	SELL	$548.35 - $738.84 $48,254 - $65,017	-88 Reduced 3.19%	2,674 $1.58 Million
Q1 2022 Apr 07, 2022	BUY	$595.12 - $698.43 $595 - $698	1 Added 0.04%	2,762 $1.93 Million
Q4 2021 Jan 07, 2022	BUY	$543.48 - $670.97 $543 - $670	1 Added 0.04%	2,761 $1.74 Million
Q3 2021 Oct 05, 2021	SELL	$574.03 - $680.96 $335,807 - $398,361	-585 Reduced 17.49%	2,760 $1.67 Million
Q2 2021 Aug 02, 2021	BUY	$472.8 - $558.54 $1.58 Million - $1.87 Million	3,345 New	3,345 $1.95 Million
Q4 2018 Jan 30, 2019	SELL	$335.82 - $403.04 $11,082 - $13,300	-33 Closed	0 $0
Q1 2018 Apr 24, 2018	BUY	$315.82 - $393.78 $10,422 - $12,994	33 New	33 $11,000

Others Institutions Holding REGN

# of Institutions

1,480

Shares Held

85.7M

Call Options Held

908K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $90.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Adam, LLC with notifications on news.

Account